Hatteras Venture Advisors III, LLC
Insider CIK 1674177 · PHAS 10% owner · CLSD 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 52,690 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | S Sale deriv | 2018-10-22 | 2018-10-24 | 994 | $5.00 | $5.0K | 40,420 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | X Exercise deriv | 2018-10-22 | 2018-10-24 | 41,414 | $0.12 | $5.0K | 41,414 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | S Sale deriv | 2018-10-22 | 2018-10-24 | 104 | $5.00 | $520 | 13,558 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | X Exercise deriv | 2018-10-22 | 2018-10-24 | 4,309 | $0.12 | $517 | 13,662 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | X Exercise deriv | 2018-10-22 | 2018-10-24 | 4,309 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | S Sale deriv | 2018-10-22 | 2018-10-24 | 1,139 | $5.00 | $5.7K | 149,320 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | X Exercise deriv | 2018-10-22 | 2018-10-24 | 47,458 | $0.12 | $5.7K | 150,459 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | X Exercise deriv | 2018-10-22 | 2018-10-24 | 47,458 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | S Sale deriv | 2018-10-22 | 2018-10-24 | 42 | $5.00 | $210 | 94,874 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | X Exercise deriv | 2018-10-22 | 2018-10-24 | 1,731 | $0.12 | $208 | 94,916 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | X Exercise deriv | 2018-10-22 | 2018-10-24 | 1,731 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | S Sale deriv | 2018-10-22 | 2018-10-24 | 458 | $5.00 | $2.3K | 1,044,764 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | X Exercise deriv | 2018-10-22 | 2018-10-24 | 19,061 | $0.12 | $2.3K | 1,045,222 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | X Exercise deriv | 2018-10-22 | 2018-10-24 | 19,061 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 42,530 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 3,862 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 4,846 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 174,699 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 13,609 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 1,044,764 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 94,874 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 149,320 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 13,558 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 40,420 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 272,107 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 24,709 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 226,061 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | X Exercise deriv | 2018-10-22 | 2018-10-24 | 41,414 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion | 2018-10-22 | 2018-10-24 | 4,846 | — | $0 | 4,846 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | P Buy | 2018-10-22 | 2018-10-24 | 12,487 | $5.00 | $62.4K | 163,099 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion | 2018-10-22 | 2018-10-24 | 150,612 | — | $0 | 150,612 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | P Buy | 2018-10-22 | 2018-10-24 | 137,513 | $5.00 | $687.6K | 1,820,933 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion | 2018-10-22 | 2018-10-24 | 266,481 | — | $0 | 266,481 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion | 2018-10-22 | 2018-10-24 | 52,690 | — | $0 | 52,690 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | P Buy | 2018-10-22 | 2018-10-24 | 150,000 | $5.00 | $750.0K | 416,481 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion | 2018-10-22 | 2018-10-24 | 1,683,420 | — | $0 | 1,683,420 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | S Sale | 2017-01-19 | 2017-01-19 | 6,478 | $8.22 | $53.2K | 1,757,719 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | S Sale | 2017-01-18 | 2017-01-19 | 10,457 | $8.64 | $90.3K | 1,764,197 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | S Sale | 2017-01-17 | 2017-01-19 | 8,366 | $8.92 | $74.6K | 1,774,654 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | X Exercise deriv | 2016-06-07 | 2016-06-07 | 1,805 | — | $0 | 0 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | X Exercise deriv | 2016-06-07 | 2016-06-07 | 19,900 | — | $0 | 0 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | C Conversion deriv | 2016-06-07 | 2016-06-07 | 337,898 | — | $0 | 0 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | C Conversion deriv | 2016-06-07 | 2016-06-07 | 432,940 | — | $0 | 0 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | C Conversion deriv | 2016-06-07 | 2016-06-07 | 689,388 | — | $0 | 0 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | C Conversion deriv | 2016-06-07 | 2016-06-07 | 2,035,907 | — | $0 | 0 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | P Buy | 2016-06-07 | 2016-06-07 | 107,142 | $7.00 | $750.0K | 1,783,020 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | S Sale | 2016-06-07 | 2016-06-07 | 69 | $7.00 | $483 | 1,675,878 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | X Exercise | 2016-06-07 | 2016-06-07 | 21,705 | $0.02 | $434 | 1,675,947 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | C Conversion | 2016-06-07 | 2016-06-07 | 1,598,219 | — | $0 | 1,654,242 | SEC↗ |